◆英語タイトル:Verastem Inc (VSTM) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7904
◆発行会社(調査会社):
GlobalData
◆発行日:2018年10月
◆ページ数:42
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Verastem Inc (Verastem) is a clinical-stage biopharmaceutical company with focus on the discovery, development and commercialization of drugs to treat cancer. The company’s lead product candidates include duvelisib, defactinib (VS-6063), FAK inhibitor (VS-4718) and PI3K/mTOR inhibitor (VS-5584). Duvelisib, an oral small molecule inhibitor of PI3K-delta and PI3K-gamma in Phase 2 and Phase 3 trials, is being evaluated in indolent non-Hodgkin lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). Defactinib, an oral inhibitor in Phase 1b study, is under evaluation for the treatment of pancreatic cancer, non-small cell lung cancer, mesothelioma, and ovarian cancer. Verastem’s VS-4718 and VS-5584 are being assessed for the treatment of solid tumors and lymphomas. It operates office and laboratory in Needham, Massachusetts. Verastem is headquartered in Needham, Massachusetts, the US.
Verastem Inc (VSTM) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Verastem Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verastem Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verastem Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verastem Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Verastem Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verastem Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Verastem Plans to Raise Funds through Public Offering of Securities 10
Verastem to Raise USD43 Million in Public Offering of Shares 11
Verastem Raises USD40.2 Million in Public Offering Raise of Shares 12
Verastem Raises USD35Million in Public Offering of Shares 14
Debt Offering 15
Verastem Oncology Raises USD150 Million in Private Placement of 5% Notes Due 2048 15
Verastem Inc – Key Competitors 17
Verastem Inc – Key Employees 18
Verastem Inc – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Recent Developments 20
Financial Announcements 20
Aug 08, 2018: Verastem Oncology reports second quarter 2018 financial results 20
May 03, 2018: Verastem Oncology Reports First Quarter 2018 Financial Results 23
Mar 13, 2018: Verastem Announces Year-End 2017 Financial Results 25
Nov 07, 2017: Verastem Reports Third Quarter 2017 Financial Results 27
May 10, 2017: Verastem Reports First Quarter 2017 Financial Results 30
Mar 23, 2017: Verastem Reports Year-End 2016 Financial Results 32
Corporate Communications 34
Oct 18, 2018: Verastem Oncology announces executive leadership appointments and changes 34
Aug 29, 2018: Verastem Oncology names Robert E. Gagnon as chief financial officer 35
Jan 04, 2018: Verastem Appoints Joseph Lobacki as Chief Commercial Officer 36
Jul 11, 2017: Verastem Names Julie B. Feder As Chief Financial Officer 37
May 02, 2017: Verastem Appoints Eric K. Rowinsky to the Board of Directors 38
Legal and Regulatory 39
Jun 25, 2018: Verastem Oncology to join Russell 3000 index 39
Product News 40
Jan 19, 2017: Verastem Announces Executive Leadership Appointments and Changes 40
Appendix 42
Methodology 42
About GlobalData 42
Contact Us 42
Disclaimer 42
List of Tables
Verastem Inc, Medical Equipment, Key Facts, 2017 2
Verastem Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Verastem Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verastem Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Verastem Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verastem Inc, Deals By Market, 2012 to YTD 2018 8
Verastem Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Verastem Plans to Raise Funds through Public Offering of Securities 10
Verastem to Raise USD43 Million in Public Offering of Shares 11
Verastem Raises USD40.2 Million in Public Offering Raise of Shares 12
Verastem Raises USD35Million in Public Offering of Shares 14
Verastem Oncology Raises USD150 Million in Private Placement of 5% Notes Due 2048 15
Verastem Inc, Key Competitors 17
Verastem Inc, Key Employees 18
Verastem Inc, Subsidiaries 19
List of Figures
Verastem Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Verastem Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Verastem Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Verastem Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Verastem Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Verastem Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Verastem Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Verastem Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8